Qingyu Cheng

2.3k total citations
25 papers, 857 citations indexed

About

Qingyu Cheng is a scholar working on Immunology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Qingyu Cheng has authored 25 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 14 papers in Rheumatology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Qingyu Cheng's work include Systemic Lupus Erythematosus Research (13 papers), T-cell and B-cell Immunology (10 papers) and Immune Cell Function and Interaction (6 papers). Qingyu Cheng is often cited by papers focused on Systemic Lupus Erythematosus Research (13 papers), T-cell and B-cell Immunology (10 papers) and Immune Cell Function and Interaction (6 papers). Qingyu Cheng collaborates with scholars based in Germany, China and Poland. Qingyu Cheng's co-authors include Falk Hiepe, Andreas Radbruch, Laleh Khodadadi, Bimba F. Hoyer, Tobias Alexander, Jens Klotsche, Adriano Taddeo, Aderajew Waka, Imtiaz M Mumtaz and Jürgen Rech and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.

In The Last Decade

Qingyu Cheng

23 papers receiving 851 citations

Peers

Qingyu Cheng
Erin Mangan United States
Laurence Ménard United States
Riley Myers United States
Catherine Barbey Switzerland
Jason M. Bannock United States
Erin Mangan United States
Qingyu Cheng
Citations per year, relative to Qingyu Cheng Qingyu Cheng (= 1×) peers Erin Mangan

Countries citing papers authored by Qingyu Cheng

Since Specialization
Citations

This map shows the geographic impact of Qingyu Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyu Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyu Cheng more than expected).

Fields of papers citing papers by Qingyu Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingyu Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyu Cheng. The network helps show where Qingyu Cheng may publish in the future.

Co-authorship network of co-authors of Qingyu Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Qingyu Cheng. A scholar is included among the top collaborators of Qingyu Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyu Cheng. Qingyu Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Martin, J. M., Qingyu Cheng, Sarah Laurent, et al.. (2024). B-Cell Maturation Antigen (BCMA) as a Biomarker and Potential Treatment Target in Systemic Lupus Erythematosus. International Journal of Molecular Sciences. 25(19). 10845–10845. 12 indexed citations
3.
Yang, Ziqiang, Yunru Yang, Dan Zhao, et al.. (2023). IL-4-secreting CD40L+ MAIT cells support antibody production in the peripheral blood of Heonch–Schönlein purpura patients. Inflammation Research. 73(1). 35–46. 1 indexed citations
4.
Ma, Huan, Xinghai Zhang, Peter H. Dube, et al.. (2022). Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron. Cell Research. 32(9). 831–842. 26 indexed citations
5.
Dang, Van Duc, Elodie Mohr, Franziska Szelinski, et al.. (2022). CD39 and CD326 Are Bona Fide Markers of Murine and Human Plasma Cells and Identify a Bone Marrow Specific Plasma Cell Subpopulation in Lupus. Frontiers in Immunology. 13. 873217–873217. 6 indexed citations
6.
Zhou, Yu, Yajun Wang, Qingyu Cheng, et al.. (2021). LYAR Promotes Colorectal Cancer Progression by Upregulating FSCN1 Expression and Fatty Acid Metabolism. Oxidative Medicine and Cellular Longevity. 2021(1). 9979707–9979707. 18 indexed citations
7.
Maschmeyer, Patrick, Hyun‐Dong Chang, Qingyu Cheng, et al.. (2021). Immunological memory in rheumatic inflammation — a roadblock to tolerance induction. Nature Reviews Rheumatology. 17(5). 291–305. 20 indexed citations
8.
Khodadadi, Laleh, Qingyu Cheng, Andreas Radbruch, & Falk Hiepe. (2019). The Maintenance of Memory Plasma Cells. Frontiers in Immunology. 10. 721–721. 130 indexed citations
9.
Cheng, Qingyu, Andreas Pelz, Bimba F. Hoyer, et al.. (2019). AB0028 SELECTIVE DEPLETION OF PLASMA CELLS IN VIVOBASED ON SPECIFICITY OF SECRETED ANTIBODIES. Annals of the Rheumatic Diseases. 78. 1479–1479. 1 indexed citations
10.
Cheng, Qingyu, Andreas Pelz, Adriano Taddeo, et al.. (2019). Selective depletion of plasma cells in vivo based on the specificity of their secreted antibodies. European Journal of Immunology. 50(2). 284–291. 21 indexed citations
11.
Takaya, Akiko, Shintaro Hojyo, Tsung-Yen Wu, et al.. (2019). Salmonella SiiE prevents an efficient humoral immune memory by interfering with IgG + plasma cell persistence in the bone marrow. Proceedings of the National Academy of Sciences. 116(15). 7425–7430. 34 indexed citations
12.
Alexander, Tobias, Qingyu Cheng, Jens Klotsche, et al.. (2018). Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursors. European Journal of Immunology. 48(9). 1573–1579. 53 indexed citations
13.
Cao, Jun, Qing Li, Yang Lv, et al.. (2016). Hepatocellular Carcinoma-propagating Cells are Detectable by Side Population Analysis and Possess an Expression Profile Reflective of a Primitive Origin. Scientific Reports. 6(1). 34856–34856. 18 indexed citations
14.
Khodadadi, Laleh, Qingyu Cheng, Tobias Alexander, et al.. (2015). Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice. PLoS ONE. 10(8). e0135081–e0135081. 40 indexed citations
16.
Winter, Oliver, et al.. (2015). Analyzing pathogenic (double-stranded (ds) DNA-specific) plasma cells via immunofluorescence microscopy. Arthritis Research & Therapy. 17(1). 293–293. 6 indexed citations
17.
Alexander, Tobias, Jens Klotsche, Anja A. Kühl, et al.. (2015). The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus. Annals of the Rheumatic Diseases. 74(7). 1474–1478. 256 indexed citations
18.
Cheng, Qingyu, Imtiaz M Mumtaz, Laleh Khodadadi, et al.. (2013). Autoantibodies from long-lived ‘memory’ plasma cells of NZB/W mice drive immune complex nephritis. Annals of the Rheumatic Diseases. 72(12). 2011–2017. 59 indexed citations
19.
Mumtaz, Imtiaz M, Bimba F. Hoyer, Daniel Panne, et al.. (2012). Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: Implications for the treatment of autoimmunity. Journal of Autoimmunity. 39(3). 180–188. 53 indexed citations
20.
Cheng, Qingyu, et al.. (2007). Development of lateral-flow immunoassay for WSSV with polyclonal antibodies raised against recombinant VP (19+28) fusion protein. Virologica Sinica. 22(1). 61–67. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026